Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Michael Stevenson. (2020) A situation analysis of the state of supply of in vitro diagnostics in Low-Income Countries. Global Public Health 15:12, pages 1836-1846.
Read now
Read now
Michael A. Stevenson. (2018) Geneva–Seattle collaboration in support of developing country vaccine manufacturing. Global Public Health 13:4, pages 426-441.
Read now
Read now
Emmanuel Vidor & Benoit Soubeyrand. (2016) Manufacturing DTaP-based combination vaccines: industrial challenges around essential public health tools. Expert Review of Vaccines 15:12, pages 1575-1582.
Read now
Read now
Articles from other publishers (16)
Brian Kelley, Todd Renshaw & Michael Kamarck. (2021) Process and operations strategies to enable global access to antibody therapies. Biotechnology Progress 37:3.
Crossref
Crossref
Zuzana Strizova, Jitka Smetanova, Jirina Bartunkova & Tomas Milota. (2021) Principles and Challenges in anti-COVID-19 Vaccine Development. International Archives of Allergy and Immunology 182:4, pages 339-349.
Crossref
Crossref
Li Zhaolong, Fu Guanghua, Feng Zhihua, Chen Jianhua, Shi Shaohua, Liu Rongchang, Cheng Longfei, Chen Hongmei, Wan Chunhe & Huang Yu. (2020) Evaluation of a novel inactivated vaccine against duck circovirus in muscovy ducks. Veterinary Microbiology 241, pages 108574.
Crossref
Crossref
Scott McLachlan, Evangelia Kyrimi, Kudakwashe Dube & Norman Fenton. 2020. Biomedical Engineering Systems and Technologies. Biomedical Engineering Systems and Technologies
429
452
.
Fatima Tauqeer, Kirsten Myhr & Unni Gopinathan. (2019) Institutional barriers and enablers to implementing and complying with internationally accepted quality standards in the local pharmaceutical industry of Pakistan: a qualitative study. Health Policy and Planning 34:6, pages 440-449.
Crossref
Crossref
Aurelia Nguyen & Nina Schwalbe. (2019) Apples and oranges? Can second generation vaccines become as low cost as generic medicines?. Vaccine 37:22, pages 2910-2914.
Crossref
Crossref
Nicholas Luter, Ritu Kumar, Dai Hozumi, Tina Lorenson, Shannon Larsen, Bhavya Gowda & Amie Batson. (2017) An updated methodology to review developing-country vaccine manufacturer viability. Vaccine 35:31, pages 3897-3903.
Crossref
Crossref
Bettina Klug, James S. Robertson, Richard C. Condit, Stephen J. Seligman, Marian P. Laderoute, Rebecca Sheets, Anna-Lise Williamson, Marc Gurwith, Sonali Kochhar, Louisa Chapman, Baevin Carbery, Lisa M. Mac & Robert T. Chen. (2016) Adventitious agents and live viral vectored vaccines: Considerations for archiving samples of biological materials for retrospective analysis. Vaccine 34:51, pages 6617-6625.
Crossref
Crossref
Emily P. Wen, Ronald Ellis & Narahari S. PujarNarahari S. Pujar, Sangeetha L. Sagar & Ann L. Lee. 2014. Vaccine Development and Manufacturing. Vaccine Development and Manufacturing
1
24
.
Miloud KaddarJulie MilstienSarah Schmitt. (2014) Impact of BRICS’ investment in vaccine development on the global vaccine market. Bulletin of the World Health Organization 92:6, pages 436-446.
Crossref
Crossref
Kate H. Rademacher, Heather L. Vahdat, Laneta Dorflinger, Derek H. Owen & Markus J. Steiner. 2014. Critical Issues in Reproductive Health. Critical Issues in Reproductive Health
285
306
.
Sonia Pagliusi, Luciana C.C. Leite, Mahima Datla, Morena Makhoana, Yongzhong Gao, Mahendra Suhardono, Suresh Jadhav, Gutla V.J.A. Harshavardhan & Akira Homma. (2013) Developing Countries Vaccine Manufacturers Network: Doing good by making high-quality vaccines affordable for all. Vaccine 31, pages B176-B183.
Crossref
Crossref
Maria de los Angeles Cortes, Daniel Cardoso, James Fitzgerald & Jose Luis DiFabio. (2012) Public vaccine manufacturing capacity in the Latin American and Caribbean region: Current status and perspectives. Biologicals 40:1, pages 3-14.
Crossref
Crossref
Siniša Tomić, Anita Sučić & Adrijana Martinac. (2010) Good Manufacturing Practice: The Role of Local Manufacturers and Competent Authorities. Archives of Industrial Hygiene and Toxicology 61:4, pages 425-436.
Crossref
Crossref
Julie B. Milstien & Miloud Kaddar. (2010) The role of emerging manufacturers in access to innovative vaccines of public health importance. Vaccine 28:9, pages 2115-2121.
Crossref
Crossref
Julie Milstien. (2009) Challenges and potential solutions to innovative vaccine development for developing countries. Procedia in Vaccinology 1:1, pages 183-188.
Crossref
Crossref